Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by NightHawk1987on May 25, 2020 3:23pm
184 Views
Post# 31070072

Thoughts on today's NR

Thoughts on today's NRFirst off, thank goodness. Second off, why today? This is the only bug I have to pick with algernon. Timing. I'm in management. I deal with this sort of thing. And I cant figure it out. US holliday, with US news. As my rants before, the us ind hasn't made sense either, so what do we have here and why. If it was me, in order to put a news release out on a US Holliday (which is just bad business) it would have to be for a reason. Maybe the hopper is so full, something HAD to spill over and get released. This is my hope. To make room for bigger news (Korea) tomorrow when investers are thirsty after a 3 day weekend. Money will be plenty abundant tomorrow. The info didn't come to them today, or yesterday. Probably late last week. So why now.... I sure hope they have half a PR brain and tomorrow will bring better news, or they are simply clueless with advertising to their demographic. Which should be their top 3 or 4 priority.
<< Previous
Bullboard Posts
Next >>